Cécile Artaud

827 total citations
19 papers, 590 citations indexed

About

Cécile Artaud is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Cécile Artaud has authored 19 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Cécile Artaud's work include Glycosylation and Glycoproteins Research (9 papers), Immunotherapy and Immune Responses (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Cécile Artaud is often cited by papers focused on Glycosylation and Glycoproteins Research (9 papers), Immunotherapy and Immune Responses (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Cécile Artaud collaborates with scholars based in United States, France and Greece. Cécile Artaud's co-authors include Thomas Kieber‐Emmons, Behjatolah Monzavi‐Karbassi, Fariba Jousheghany, Leah Hennings, Marie‐Lise Gougeon, Michel Zérah, Jean‐Michel Heard, Jérôme Ausseil, Kumaran Deiva and Marc Tardieu and has published in prestigious journals such as The Journal of Immunology, Cancer Research and The Lancet Neurology.

In The Last Decade

Cécile Artaud

19 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cécile Artaud United States 14 358 167 95 88 84 19 590
R.T. Kidmose Denmark 9 343 1.0× 204 1.2× 82 0.9× 40 0.5× 85 1.0× 11 704
Charlotte Widberg Australia 8 370 1.0× 81 0.5× 99 1.0× 24 0.3× 137 1.6× 9 717
Mhairi Skinner Canada 10 551 1.5× 119 0.7× 58 0.6× 73 0.8× 158 1.9× 28 888
Irina Mirkina Austria 16 191 0.5× 308 1.8× 21 0.2× 34 0.4× 35 0.4× 26 590
Stephanie Zimmermann Germany 13 348 1.0× 308 1.8× 27 0.3× 45 0.5× 33 0.4× 15 721
Catherine Moss United Kingdom 15 551 1.5× 183 1.1× 102 1.1× 49 0.6× 70 0.8× 27 919
Z. Sean Juo United States 9 511 1.4× 430 2.6× 102 1.1× 79 0.9× 60 0.7× 9 1.2k
Sherry L. LaPorte United States 9 363 1.0× 510 3.1× 36 0.4× 146 1.7× 26 0.3× 11 1.2k
Rajesh Jayachandran Switzerland 11 419 1.2× 311 1.9× 56 0.6× 14 0.2× 95 1.1× 20 909
Jenson Lim United Kingdom 15 220 0.6× 252 1.5× 34 0.4× 32 0.4× 94 1.1× 23 679

Countries citing papers authored by Cécile Artaud

Since Specialization
Citations

This map shows the geographic impact of Cécile Artaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Artaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Artaud more than expected).

Fields of papers citing papers by Cécile Artaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Artaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Artaud. The network helps show where Cécile Artaud may publish in the future.

Co-authorship network of co-authors of Cécile Artaud

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Artaud. A scholar is included among the top collaborators of Cécile Artaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Artaud. Cécile Artaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gougeon, Marie‐Lise, Jérôme Ausseil, Michel Zérah, et al.. (2021). Cell-Mediated Immunity to NAGLU Transgene Following Intracerebral Gene Therapy in Children With Mucopolysaccharidosis Type IIIB Syndrome. Frontiers in Immunology. 12. 655478–655478. 29 indexed citations
2.
Rosenbaum, Pierre, Cécile Artaud, Sylvie Bay, et al.. (2020). The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients. Cancer Immunology Immunotherapy. 69(5). 703–716. 41 indexed citations
3.
4.
Artaud, Cécile, et al.. (2019). Vaccine Development: From Preclinical Studies to Phase 1/2 Clinical Trials. Methods in molecular biology. 2013. 165–176. 13 indexed citations
5.
6.
Tardieu, Marc, Michel Zérah, Marie‐Lise Gougeon, et al.. (2017). Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial. The Lancet Neurology. 16(9). 712–720. 151 indexed citations
7.
Tardieu, Marc, Michel Zérah, Marie‐Lise Gougeon, et al.. (2017). Intracerebral administration of rAAV2/5hNAGLU vector in children with MPS IIIB: results at 30 months of a phase I/II trial. Molecular Genetics and Metabolism. 120(1-2). S130–S130. 1 indexed citations
8.
Laubreton, Daphné, Sylvie Bay, Christine Sedlik, et al.. (2016). The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity. Cancer Immunology Immunotherapy. 65(3). 315–325. 22 indexed citations
9.
Ganneau, Christelle, Catherine Simenel, Yves‐Marie Coïc, et al.. (2016). Large-scale synthesis and structural analysis of a synthetic glycopeptide dendrimer as an anti-cancer vaccine candidate. Organic & Biomolecular Chemistry. 15(1). 114–123. 14 indexed citations
10.
Hennings, Leah, Cécile Artaud, Fariba Jousheghany, et al.. (2011). Carbohydrate Mimetic Peptides Augment Carbohydrate-Reactive Immune Responses in the Absence of Immune Pathology. Cancers. 3(4). 4151–4169. 16 indexed citations
11.
Monzavi‐Karbassi, Behjatolah, Leah Hennings, Cécile Artaud, et al.. (2007). Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma. Vaccine. 25(16). 3022–3031. 29 indexed citations
12.
Monzavi‐Karbassi, Behjatolah, J. Steven Stanley, Leah Hennings, et al.. (2006). Chondroitin sulfate glycosaminoglycans as major P‐selectin ligands on metastatic breast cancer cell lines. International Journal of Cancer. 120(6). 1179–1191. 74 indexed citations
13.
Monzavi‐Karbassi, Behjatolah, Anastas Pashov, Fariba Jousheghany, Cécile Artaud, & Thomas Kieber‐Emmons. (2006). Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine. International Journal of Molecular Medicine. 17(6). 1045–52. 8 indexed citations
14.
Monzavi‐Karbassi, Behjatolah, Fariba Jousheghany, Cécile Artaud, et al.. (2005). Deficiency in surface expression of E‐selectin ligand promotes lung colonization in a mouse model of breast cancer. International Journal of Cancer. 117(3). 398–408. 19 indexed citations
15.
Monzavi‐Karbassi, Behjatolah, Cécile Artaud, Fariba Jousheghany, et al.. (2005). Reduction of Spontaneous Metastases through Induction of Carbohydrate Cross-Reactive Apoptotic Antibodies. The Journal of Immunology. 174(11). 7057–7065. 23 indexed citations
16.
Monzavi‐Karbassi, Behjatolah, et al.. (2005). 1H-NMR metabolic markers of malignancy correlate with spontaneous metastases in a murine mammary tumor model. International Journal of Oncology. 27(1). 257–63. 10 indexed citations
17.
Monzavi‐Karbassi, Behjatolah, et al.. (2004). A Mimic of Tumor Rejection Antigen-Associated Carbohydrates Mediates an Antitumor Cellular Response. Cancer Research. 64(6). 2162–2166. 31 indexed citations
18.
Luo, Ping, Behjatolah Monzavi‐Karbassi, Andrew Lees, et al.. (2003). Peptide mimotopes as prototypic templates of broad-spectrum surrogates of carbohydrate antigens.. PubMed. 49(2). 245–54. 13 indexed citations
19.
Lacroix‐Desmazes, Sébastien, Namita Misra, Jagadeesh Bayry, et al.. (2002). Pathophysiology of inhibitors to factor VIII in patients with haemophilia A. Haemophilia. 8(3). 273–279. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R.T. Kidmose Breakdown of academic impact, for papers by Charlotte Widberg Breakdown of academic impact, for papers by Mhairi Skinner Breakdown of academic impact, for papers by Irina Mirkina Breakdown of academic impact, for papers by Stephanie Zimmermann Breakdown of academic impact, for papers by Catherine Moss Breakdown of academic impact, for papers by Z. Sean Juo Breakdown of academic impact, for papers by Sherry L. LaPorte Breakdown of academic impact, for papers by Rajesh Jayachandran Breakdown of academic impact, for papers by Jenson Lim
Rankless by CCL
2026